GSK Signs Record Israeli Settlement Of Avandia Diabetes Drug Suit
This article was originally published in PharmAsia News
Executive Summary
An Israeli class-action suit against GlaxoSmithKline over its Avandia (rosiglitazone) diabetes drug has reached a record compromise settlement by a drug maker in Israel.